Author: PharmaTimes

Antisoma says it is to acquire privately-owned US cancer company, Aptamera, in a £11.5 million pound share-based deal that brings the UK firm the rights to a novel anti-cancer agent, known as AGRO100.

Kyran McLaughlin is assuming the position of non-executive chairman of the board of directors at Elan Corporation, following the departure of Garo Armen who is stepping down from the post with immediate effect.

US citizens hoping to buy prescription drugs from internet sites based in Canada could be banned if plans currently being debated win approval, according to Industry reports.

Schering AG has suffered a potential major setback after it received an approvable letter from the US Food and Drug Administration for its anti-cancer agent, Bonefos (clodronate). A dearth of information from the German company on what it must do in order to win final approval led to a 6% drop in the firm’s share price as investors grew concerned that additional trials could be requested.

Genentech says that the US Food and Drug Administration has approved an update to the product label for its highly-touted colorectal cancer agent, Avastin (bevacizumab), which will now include a warning about an increased risk of serious and potentially fatal blood clots in patients taking the drug.